BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10392216)

  • 1. Intracavitary chemotherapy of polycystic craniopharyngioma with bleomycin.
    Savas A; Arasil E; Batay F; Selcuki M; Kanpolat Y
    Acta Neurochir (Wien); 1999; 141(5):547-8; discussion 549. PubMed ID: 10392216
    [No Abstract]   [Full Text] [Related]  

  • 2. [A 21-year old patient with hypernatraemia after intracranial tumour surgery--a case report].
    Kuźmińska M
    Przegl Lek; 2015; 72(8):449-52. PubMed ID: 26827564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed neurotoxic complication of intracavitary bleomycin therapy for craniopharyngioma in a child who had previously undergone radiosurgery. Case report.
    Belen D; Er U; Yigitkanli K; Bolay H
    J Neurosurg; 2007 May; 106(5 Suppl):391-3. PubMed ID: 17566208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic craniopharyngioma: trans-sphenoidal surgery and intra-cystic apposition of "bleomycin wax".
    Fraioli MF; Moschettoni L; Catena E; Fraioli C
    Acta Neurochir (Wien); 2010 Feb; 152(2):293-6. PubMed ID: 19390776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoural bleomycin as a treatment for recurrent cystic craniopharyngioma. Case report and review of the literature.
    Alén JF; Boto GR; Lagares A; de la Lama A; Gómez PA; Lobato RD
    Neurocirugia (Astur); 2002 Dec; 13(6):479-85; discussion 485. PubMed ID: 12529778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary results of intracavitary treatment of craniopharyngioma with bleomycin.
    Broggi G; Giorgi C; Franzini A; Servello D; Solero CL
    J Neurosurg Sci; 1989; 33(1):145-8. PubMed ID: 2476533
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiological findings following postsurgical intratumoral bleomycin injection for cystic craniopharyngioma.
    Kim SD; Park JY; Park J; Lee JB; Kim SH; Lim DJ
    Clin Neurol Neurosurg; 2007 Apr; 109(3):236-41. PubMed ID: 17046151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of bleomycin in intratumoral chemotherapy for cystic craniopharyngioma. Case report.
    Cavalheiro S; Sparapani FV; Franco JO; da Silva MC; Braga FM
    J Neurosurg; 1996 Jan; 84(1):124-6. PubMed ID: 8613819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypopituitarism oddities: craniopharyngiomas.
    Karavitaki N
    Horm Res; 2007; 68 Suppl 5():151-3. PubMed ID: 18174734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroradiological findings of bleomycin leakage in cystic craniopharyngioma. Report of three cases.
    Lafay-Cousin L; Bartels U; Raybaud C; Kulkarni AV; Guger S; Huang A; Bouffet E
    J Neurosurg; 2007 Oct; 107(4 Suppl):318-23. PubMed ID: 17941498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The ocular manifestations in craniopharyngioma].
    Mocanu C
    Oftalmologia; 1992; 36(3):277-81. PubMed ID: 1520687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HORMONE SUBSTITUTION AFTER GASTRIC BYPASS SURGERY IN PATIENTS WITH HYPOPITUITARISM SECONDARY TO CRANIOPHARYNGIOMA.
    Wolf P; Winhofer Y; Smajis S; Kruschitz R; Schindler K; Gessl A; Riedl M; Vila G; Raber W; Langer F; Prager G; Ludvik B; Luger A; Krebs M
    Endocr Pract; 2016 May; 22(5):595-601. PubMed ID: 26789341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetes insipidus and adipsic hypernatremia in a patient with a craniopharyngioma].
    Macías Batista A; Martínez Martín FJ; de Pablos Velasco PL
    An Med Interna; 1999 Feb; 16(2):87-8. PubMed ID: 10193001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with craniopharyngiomas: therapeutical difficulties with growth hormone.
    Cannavò S; Marini F; Trimarchi F
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):56-60. PubMed ID: 19020388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncommon presentation of craniopharyngioma with anemia in an adolescent.
    Kamal K; Ozgönenel B; Rabah R; Bhambhani K; Savaşan S
    Pediatr Blood Cancer; 2006 Jan; 46(1):117-8. PubMed ID: 16047369
    [No Abstract]   [Full Text] [Related]  

  • 16. Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement.
    Yuen KCJ; Mattsson AF; Burman P; Erfurth EM; Camacho-Hubner C; Fox JL; Verhelst J; Geffner ME; Abs R
    J Clin Endocrinol Metab; 2018 Feb; 103(2):768-777. PubMed ID: 29029108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A descent thing to do for the chiasm.
    Kosmorsky GS; Straga JM
    J Neuroophthalmol; 1997 Mar; 17(1):53-6. PubMed ID: 9093964
    [No Abstract]   [Full Text] [Related]  

  • 18. Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke's cleft cyst, and arachnoid cyst.
    Shin JL; Asa SL; Woodhouse LJ; Smyth HS; Ezzat S
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3972-82. PubMed ID: 10566636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary deficiency in patients with pituitary tumours.
    Martin FI
    Australas Ann Med; 1966 Feb; 15(1):40-50. PubMed ID: 5913242
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary: navigating a data desert: cochrane leaves the question of intracystic bleomycin unanswered in craniopharyngioma.
    Plastaras JP; Lustig RA; Hill-Kayser CE
    Neurosurgery; 2012 Nov; 71(5):E1062-3. PubMed ID: 22902335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.